OKYO Pharma Ltd ADR (OKYO) Financials

$1.51

$-0.06 (-3.82%)

As on 08-Sep-2026 11:34EDT

Market cap

$82 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

6.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	6.69	0.00	7.51	6.75	0.01	0.81
Gross Profit	-6.69	0.00	-7.51	-6.75	-0.01	-0.81
Operating Expenses	1.81	7.19	8.24	6.34	6.22	3.32
Operating Profit (EBIT)	-8.50	-7.19	-15.75	-13.09	-6.23	-4.13
Other Income	--	--	--	--	--	--
Profit before Tax	-8.94	-7.97	-16.80	-13.28	-6.22	-3.38
Provision for Tax	0.01	-3.26	0.02	-0.01	-0.79	-0.03
Profit after Tax (Net Income)	-8.95	-4.71	-16.83	-13.27	-5.43	-3.35
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-3.98	-3.00

Liabilities ($ Mln)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	12.34	-5.55	-5.88	-2.05	2.95	5.32
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	--	0.56	0.06
Current Liabilities	8.64	9.23	7.42	7.26	1.35	1.71
Total Liabilities	20.98	3.68	1.54	5.20	4.30	7.09

Assets ($ Mln)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	0.01	0.00	0.00	0.01	0.01	0.10
Current Assets	20.97	3.68	1.54	5.20	4.30	6.99
Total Assets	20.98	3.68	1.54	5.20	4.30	7.09
Total Debt*	--	--	--	2.22	--	0.10
Net Current Assets	12.33	-5.55	-5.88	-2.06	2.94	3.83

Cashflow ($ Mln)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	-5.94	-1.81	-9.49	-7.70	-5.47	-1.60
Cash Flow from Investing Activities	-6.01	0.00	--	-0.01	0.00	-0.02
Cash from Financing Activities	25.02	2.66	6.21	9.32	2.15	7.83
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS ($)	-0.24	-0.12	-0.51	-0.58	-0.34	-0.32
Cash EPS ($)	-0.24	-0.12	-0.51	-0.58	-0.34	-0.32
Adjusted Book Value ($)	0.33	--	--	--	0.18	0.50
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-0.16	-0.05	-0.29	-0.34	-0.34	-0.15
Free Cash Flow per Share ($)	-0.16	-0.05	-0.29	-0.34	-0.34	-0.15

Profitability Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	-263.80	82.35	588.54	-853.70	-129.84	-126.47
ROE (%)	-263.80	82.35	424.20	-2,968.58	-131.39	-129.51
ROA (%)	-72.60	-180.37	-498.89	-279.28	-95.35	-87.24
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-19.49	55.01	-20.34	-110.50	-50.40	-172.17
Net Profit Growth (%)	-90.16	72.03	-26.77	-144.37	-61.93	-117.49
EPS Growth (%)	-1.01	0.77	0.12	-0.72	-0.06	-1.01
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	-6.73	-10.66	-2.92	-2.89	--	--
Price / Book Value	4.88	-9.04	-8.36	-18.71	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-4.68	-6.86	-3.07	-2.80	--	--
Close Price ($)	1.61	1.27	1.49	1.68	--	--
High Price ($)	3.35	1.74	3.25	7.00	--	--
Low Price ($)	1.03	0.81	0.92	1.29	--	--
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	--	--	--	-1.08	--	0.02
Short term debt to equity ratio	--	--	--	-1.08	--	0.01
Current Ratio	2.43	0.40	0.21	0.72	3.17	4.09
Quick Ratio	--	--	--	0.69	3.18	4.09
Interest Coverage	-17.87	-8.02	-14.95	-135.36	--	-3,681.07

Operating Efficiency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	8.29	4.57	-20.47	-0.17
Payable days	410.43	999,564.98	174.01	41.71	10,236.26	181.10
Cash Conversion Cycle	--	--	--	--	--	--